US Food and Drug Administration Approval Summary: Fam-Trastuzumab Deruxtecan-nxki for Human Epidermal Growth Factor Receptor 2-Low Unresectable or Metastatic Breast Cancer
暂无分享,去创建一个
R. Pazdur | L. Amiri-Kordestani | M. Kondratovich | Shenghui Tang | J. Beaver | E. Bloomquist | Soma Ghosh | P. Narayan | C. Osgood | W. Pierce | A. Dilawari | Shyam Kalavar | S. Jafri | Zhou Feng | Prakash Jha